Location: Sweden · Frame: M&A-lead founding-partner · Judge tier: 1b · Judge Focus-44 rank: 9
Head of M&A Asker Healthcare Group (handing over to Lovisa Hedin 1-Apr-2026; leaving later 2026)
Ran Asker Healthcare's acquisition engine 2022-2026: 11 deals in 2024, 14 in 2025 incl. HSL, HNC and Novus Med — the deal machine of a Nordic tier-1 compounder.
Ran Asker's engine 11 deals 2024 + 14 in 2025 (incl. HSL, HNC, Novus Med); handover to Lovisa Hedin 1-Apr-2026; leaving 'to pursue new opportunities'.
INSITE l4-asker.md: the entire 42-row Asker corpus IS Nordh interview single-voice. 12-step process + 12-month post-deal review + "smoke and mirrors" M&A center of excellence + "wrong entrepreneur" failure phrase. Primary-source access to his own operator worldview.
UNLOCKING_2026-Q2
Outreach window: APPROACH POST-TRANSITION Q2-2026
Discreet post-Asker-exit-date; pair with a CEO from the focus list
M&A-lead founding-partner · Asker / AddLife / Lifco engine · L4 bracket DEEP · L1=5 L2=3 L4=5 L5=3 L6=5
Path to seat: compounder_ma_lead
Data gap: Age; Swedish non-compete (9-18mo); optics with Asker
Data gap: L6 evidence-only rescore: Explicitly leaving Asker 'to pursue new opportunities'; Hedin handover 1-Apr-2026 confirms transition